With our products, we ensure the supply of essential goods

The products and services of K+S are crucial for supplying the population in the fields of medicine, pharmaceuticals, food production, agriculture and animal feed. By using our underground caverns, we also contribute to an orderly waste management system.

K+S pharmaceutical salt (APISAL®) is produced by a highly developed evaporated salt process and contains no additives.

Transportation medium for the corona vaccine

The Biontech/Pfizer corona vaccine COMIRNATY® is only applicable with the addition of high-purity sodium chloride solution. K+S is one of the largest manufacturers of the pharmaceutical-grade sodium chloride required for this purpose.

K+S Aktiengesellschaft

Figures for Q3 2020

In an interview, Dr. Burkhard Lohr, Chairman of the Board of Executive Directors of K+S AG, explains the business development of the company in the third quarter of 2020 and provides an outlook for the year as a whole. He also talks about the status of the restructuring of the administration.

Press release of November 12, 2020

Higher Q3-EBITDA – Full-Year Outlook Confirmed

Overall, K+S achieved a solid result in the third quarter despite the persistently challenging environment. EBITD operating earnings rose significantly to € 96 million (Q3/2019: €  81 million).

Press release of November 4, 2020

K+S cleans up balance sheet

The K+S Board of Executive Directors has adjusted its long-term assumptions against the background of the realignment of the Company and the sale of the Americas operating unit.

Press release of October 5, 2020

Sales agreement signed: K+S sells its Americas salt business to Stone Canyon Industries Holding, Mark Demetree and Affiliates

Today, K+S Aktiengesellschaft signed a contract to sell its Americas salt business bundled together as the Americas Operating Unit to Stone Canyon Industries Holdings LLC (“SCIH”), Mark Demetree and affiliates.

corona pandemic

Dealing with the corona pandemic

It is part of our social responsibility to serve the needs of our customers in the medical, pharmaceutical, food production, animal feed and agricultural sectors in the best possible way and to ensure the safe disposal of waste.

K+S Annual Report 2019

Annual Report 2019

Read all numbers and facts about K+S in our new 2019 Annual Report.

Digitalization in Africa’s agriculture

Together with local partners, K+S offers the EzyAgric App in Africa, which helps small-scale farmers to improve their harvests thereby raising their standard of living.

K+S Innovation

New ideas for a successful future

Innovation drives our mission to enrich life through the sustainable extraction and refinement of minerals into essential products for our customers.

Focus on four business segments

K+S's business is focused on four segments: agriculture, industry, consumers, and communities. The same applies in all segments: The customer is the focus of our activities.

About K+S sites

Over 90 sites on five continents

Regionally sourced, worldwide. K+S has production sites in Europe, North, Central, and South America, with additional distribution sites in Africa and Asia.

1 company, 1,000 possibilities: The wide range of career opportunities at K+S

More than 14,000 employees work for us at more than 90 locations worldwide. Here you will find detailed information about national and international entry and career opportunities.

We care

We strive for sustainability, because we acknowledge our responsibility to the people, the environment, the communities, and the economy in the regions in which we operate.

K+S Sustainability


As a provider of mineral products for the areas of Agriculture, Industry, Consumers and Communities, we think and act with foresight.